These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 25768905)
21. LANP mediates neuritic pathology in Spinocerebellar ataxia type 1. Cvetanovic M; Kular RK; Opal P Neurobiol Dis; 2012 Dec; 48(3):526-32. PubMed ID: 22884877 [TBL] [Abstract][Full Text] [Related]
22. Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Cummings CJ; Sun Y; Opal P; Antalffy B; Mestril R; Orr HT; Dillmann WH; Zoghbi HY Hum Mol Genet; 2001 Jul; 10(14):1511-8. PubMed ID: 11448943 [TBL] [Abstract][Full Text] [Related]
23. RAS-MAPK-MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1. Park J; Al-Ramahi I; Tan Q; Mollema N; Diaz-Garcia JR; Gallego-Flores T; Lu HC; Lagalwar S; Duvick L; Kang H; Lee Y; Jafar-Nejad P; Sayegh LS; Richman R; Liu X; Gao Y; Shaw CA; Arthur JSC; Orr HT; Westbrook TF; Botas J; Zoghbi HY Nature; 2013 Jun; 498(7454):325-331. PubMed ID: 23719381 [TBL] [Abstract][Full Text] [Related]
24. Spinocerebellar ataxia type 1--modeling the pathogenesis of a polyglutamine neurodegenerative disorder in transgenic mice. Clark HB; Orr HT J Neuropathol Exp Neurol; 2000 Apr; 59(4):265-70. PubMed ID: 10759181 [TBL] [Abstract][Full Text] [Related]
25. Beyond the glutamine expansion: influence of posttranslational modifications of ataxin-1 in the pathogenesis of spinocerebellar ataxia type 1. Ju H; Kokubu H; Lim J Mol Neurobiol; 2014 Dec; 50(3):866-874. PubMed ID: 24752589 [TBL] [Abstract][Full Text] [Related]
27. Focused cerebellar laser light induced hyperthermia improves symptoms and pathology of polyglutamine disease SCA1 in a mouse model. Hearst SM; Shao Q; Lopez M; Raucher D; Vig PJ Cerebellum; 2014 Oct; 13(5):596-606. PubMed ID: 24930030 [TBL] [Abstract][Full Text] [Related]
28. HMGB1 facilitates repair of mitochondrial DNA damage and extends the lifespan of mutant ataxin-1 knock-in mice. Ito H; Fujita K; Tagawa K; Chen X; Homma H; Sasabe T; Shimizu J; Shimizu S; Tamura T; Muramatsu S; Okazawa H EMBO Mol Med; 2015 Jan; 7(1):78-101. PubMed ID: 25510912 [TBL] [Abstract][Full Text] [Related]
29. SCA1-like disease in mice expressing wild-type ataxin-1 with a serine to aspartic acid replacement at residue 776. Duvick L; Barnes J; Ebner B; Agrawal S; Andresen M; Lim J; Giesler GJ; Zoghbi HY; Orr HT Neuron; 2010 Sep; 67(6):929-35. PubMed ID: 20869591 [TBL] [Abstract][Full Text] [Related]
30. dAtaxin-2 mediates expanded Ataxin-1-induced neurodegeneration in a Drosophila model of SCA1. Al-Ramahi I; Pérez AM; Lim J; Zhang M; Sorensen R; de Haro M; Branco J; Pulst SM; Zoghbi HY; Botas J PLoS Genet; 2007 Dec; 3(12):e234. PubMed ID: 18166084 [TBL] [Abstract][Full Text] [Related]
31. Cloning and developmental expression analysis of the murine homolog of the spinocerebellar ataxia type 1 gene (Sca1). Banfi S; Servadio A; Chung M; Capozzoli F; Duvick LA; Elde R; Zoghbi HY; Orr HT Hum Mol Genet; 1996 Jan; 5(1):33-40. PubMed ID: 8789437 [TBL] [Abstract][Full Text] [Related]
32. Broad therapeutic benefit after RNAi expression vector delivery to deep cerebellar nuclei: implications for spinocerebellar ataxia type 1 therapy. Keiser MS; Boudreau RL; Davidson BL Mol Ther; 2014 Mar; 22(3):588-595. PubMed ID: 24419082 [TBL] [Abstract][Full Text] [Related]
33. Clinical, genetic, molecular, and pathophysiological insights into spinocerebellar ataxia type 1. Matilla-Dueñas A; Goold R; Giunti P Cerebellum; 2008; 7(2):106-14. PubMed ID: 18418661 [TBL] [Abstract][Full Text] [Related]
34. Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components. Stenoien DL; Mielke M; Mancini MA Nat Cell Biol; 2002 Oct; 4(10):806-10. PubMed ID: 12360291 [TBL] [Abstract][Full Text] [Related]
35. Structural basis of the phosphorylation dependent complex formation of neurodegenerative disease protein Ataxin-1 and RBM17. Kim E; Lee Y; Choi S; Song JJ Biochem Biophys Res Commun; 2014 Jul; 449(4):399-404. PubMed ID: 24858692 [TBL] [Abstract][Full Text] [Related]
36. Amino acids in a region of ataxin-1 outside of the polyglutamine tract influence the course of disease in SCA1 transgenic mice. Skinner PJ; Vierra-Green CA; Emamian E; Zoghbi HY; Orr HT Neuromolecular Med; 2002; 1(1):33-42. PubMed ID: 12025814 [TBL] [Abstract][Full Text] [Related]
37. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Cummings CJ; Reinstein E; Sun Y; Antalffy B; Jiang Y; Ciechanover A; Orr HT; Beaudet AL; Zoghbi HY Neuron; 1999 Dec; 24(4):879-92. PubMed ID: 10624951 [TBL] [Abstract][Full Text] [Related]
38. ATXN1 protein family and CIC regulate extracellular matrix remodeling and lung alveolarization. Lee Y; Fryer JD; Kang H; Crespo-Barreto J; Bowman AB; Gao Y; Kahle JJ; Hong JS; Kheradmand F; Orr HT; Finegold MJ; Zoghbi HY Dev Cell; 2011 Oct; 21(4):746-57. PubMed ID: 22014525 [TBL] [Abstract][Full Text] [Related]
39. Spatial and Temporal Diversity of Astrocyte Phenotypes in Spinocerebellar Ataxia Type 1 Mice. Rosa JG; Hamel K; Sheeler C; Borgenheimer E; Gilliat S; Soles A; Ghannoum FJ; Sbrocco K; Handler HP; Rainwater O; Kang R; Cvetanovic M Cells; 2022 Oct; 11(20):. PubMed ID: 36291186 [TBL] [Abstract][Full Text] [Related]
40. PQBP-1 transgenic mice show a late-onset motor neuron disease-like phenotype. Okuda T; Hattori H; Takeuchi S; Shimizu J; Ueda H; Palvimo JJ; Kanazawa I; Kawano H; Nakagawa M; Okazawa H Hum Mol Genet; 2003 Apr; 12(7):711-25. PubMed ID: 12651867 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]